Published in Onco Targets Ther on November 11, 2016
Clinicopathological significance of p14(ARF) expression in lung cancer: a meta-analysis. Onco Targets Ther (2017) 0.75
Measuring inconsistency in meta-analyses. BMJ (2003) 128.20
Global cancer statistics, 2012. CA Cancer J Clin (2015) 53.52
Cancer statistics, 2016. CA Cancer J Clin (2016) 32.95
Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. N Engl J Med (2002) 24.87
Epigenetics in cancer. N Engl J Med (2008) 17.36
Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest. Cell (1995) 7.34
DNA methylation markers and early recurrence in stage I lung cancer. N Engl J Med (2008) 5.87
Rational, biologically based treatment of EGFR-mutant non-small-cell lung cancer. Nat Rev Cancer (2010) 5.82
Hypermethylation-associated inactivation indicates a tumor suppressor role for p15INK4B. Cancer Res (1996) 3.50
p16(MTS-1/CDKN2/INK4a) in cancer progression. Exp Cell Res (2001) 2.34
Meta-analysis in the design and monitoring of clinical trials. Stat Med (1996) 2.02
Comment on: Heterogeneity in meta-analysis should be expected and appropriately quantified. Int J Epidemiol (2009) 1.49
Methylation of multiple genes as a candidate biomarker in non-small cell lung cancer. Cancer Lett (2011) 1.48
Detection of promoter hypermethylation of multiple genes in the tumor and bronchoalveolar lavage of patients with lung cancer. Clin Cancer Res (2004) 1.32
Promoter methylation of DAP-kinase: association with advanced stage in non-small cell lung cancer. Oncogene (2001) 1.28
Promoter hypermethylation of RASSF1A and RUNX3 genes as an independent prognostic prediction marker in surgically resected non-small cell lung cancers. Lung Cancer (2007) 1.25
Small cell lung cancer: where do we go from here? Cancer (2014) 1.22
Gene silencing by DNA methylation in haematological malignancies. Br J Haematol (2007) 1.20
A KRAS-directed transcriptional silencing pathway that mediates the CpG island methylator phenotype. Elife (2014) 1.12
Aberrant p16 promoter methylation in smokers and former smokers with nonsmall cell lung cancer. Int J Cancer (2003) 1.09
Multiple gene methylation of nonsmall cell lung cancers evaluated with 3-dimensional microarray. Cancer (2008) 1.08
Role of TET enzymes in DNA methylation, development, and cancer. Genes Dev (2016) 1.08
Prognostic significance of p14ARF, p15INK4b, and p16INK4a inactivation in malignant peripheral nerve sheath tumors. Clin Cancer Res (2011) 1.01
Meta-analyses of gene methylation and smoking behavior in non-small cell lung cancer patients. Sci Rep (2015) 0.98
Global histone post-translational modifications and cancer: Biomarkers for diagnosis, prognosis and treatment? World J Biol Chem (2015) 0.94
Abnormal methylation of seven genes and their associations with clinical characteristics in early stage non-small cell lung cancer. Oncol Lett (2013) 0.91
Aberrant methylation of p14(ARF), p15(INK4b) and p16(INK4a) genes and location of the primary site in pulmonary squamous cell carcinoma. Pathol Int (2004) 0.91
Quantitative assessment of higher-order chromatin structure of the INK4/ARF locus in human senescent cells. Aging Cell (2012) 0.88
Association between P(16INK4a) promoter methylation and non-small cell lung cancer: a meta-analysis. PLoS One (2013) 0.88
Prognostic significance of RASSF1A promoter methylation on survival of non-small cell lung cancer patients treated with gemcitabine. Lung Cancer (2006) 0.87
Promoter methylation primarily occurs in tumor cells of patients with non-small cell lung cancer. Anticancer Res (2009) 0.87
Increase in the frequency of p16INK4 gene inactivation by hypermethylation in lung cancer during the process of metastasis and its relation to the status of p53. Clin Cancer Res (2000) 0.85
Hypermethylation of E-cadherin gene is frequent and independent of p16INK4A methylation in non-small cell lung cancer: potential prognostic implication. Oncol Rep (2004) 0.83
Epigenetic regulation of p14ARF and p16INK4A expression in cutaneous and uveal melanoma. Biochim Biophys Acta (2014) 0.83
Epigenetic marks responsible for cadmium-induced melanoma cell overgrowth. Toxicol In Vitro (2015) 0.82
A Novel Epigenetic Signature for Early Diagnosis in Lung Cancer. Clin Cancer Res (2016) 0.81
Distinguishing Lung Adenocarcinoma from Lung Squamous Cell Carcinoma by Two Hypomethylated and Three Hypermethylated Genes: A Meta-Analysis. PLoS One (2016) 0.81
Promoter methylations of RASSF1A and p16 is associated with clinicopathological features in lung cancers. J Cancer Res Ther (2016) 0.80
Expression of p15 and p15.5 products in neuroendocrine lung tumours: relationship with p15(INK4b) methylation status. Oncogene (2001) 0.80
Genetic alterations of RD(INK4/ARF) enhancer in human cancer cells. Mol Carcinog (2012) 0.80
[Promoter methylation status and protein expression of p14ARF gene in squamous cell carcinoma and adenocarcinoma of the lung]. Zhongguo Fei Ai Za Zhi (2006) 0.79
Hypermethylation of p15 gene associated with an inferior poor long-term outcome in childhood acute lymphoblastic leukemia. J Cancer Res Clin Oncol (2016) 0.77